Home » For Lab Industry, FDA Draft Guidance on NGS Testing Inseparable From Larger LDT Debate

For Lab Industry, FDA Draft Guidance on NGS Testing Inseparable From Larger LDT Debate

Jul 11, 2016
|
Turna Ray
Premium

NEW YORK (GenomeWeb) – After releasing white papers, holding several public workshops, and listening to stakeholder feedback, the US Food and Drug Administration has released two draft guidances outlining how it might review the analytical and clinical validity of next-generation sequencing tests.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Now You Can Read Them, Now You Can't

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

The Mouths of Heavy Drinkers Are Disgusting

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

For Health or For Fun?

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

This Week in Genome Research

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more. 

May
01
Featured Webinar

Analytical Validation of a Liquid Biopsy Assay for High-Sensitivity Molecular Profiling

Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May
03
Featured Webinar

GenomeWeb/ABRF 2018 Webinar Series: Novel Tools for Multidimensional Profiling of Single Cells

Sponsored by
Canon BioMedical

This webinar will introduce new technologies that enable multidimensional measurements from single cells to obtain a more complete picture of a cell’s phenotype and gene expression.

May
08
Featured Webinar

Structural Variation Detection by Proximity Ligation from FFPE Tumor Tissue

Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.

May
10
Featured Webinar

Mining the Post-Mortem Human Brain for Neurodegenerative Markers: Deep Sequencing of Cell Type-Specific Transcriptomes

Sponsored by
NuGEN

This webinar will highlight the use of high-throughput sequencing of post-mortem human brain tissue to identify neurodegenerative markers and identify potential drug targets.

What's Popular?

In Sequencing

  1. Thermo Fisher Scientific Reports 23 Percent Revenue Growth in Q1

  2. ABRF Single-Cell RNA-Seq Platform Comparison Finds Similar Performance, Drawbacks for Each

  3. Illumina Q1 2018 Revenues Rise 31 Percent

  4. 3,000 Rice Genomes Project Sequences Reveal Asian Rice History, Diversity

  5. Loss-of-Function, Truncating Variants in UK Biobank Data Point to New Drug Targets

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.